The GLP-1 foundation: Semaglutide Semaglutide is a GLP-1 medication that mimics the GLP-1 incretin hormone produced in the intestines
A Danish nationwide cohort study also reported a lower risk of corticosteroid use and hospitalization in IBD patients with DM2 undergoing GLP-1 RAs rather than other antidiabetic treatments (98)
The preparation method according to any one of claims 1 to 3, wherein the coupling in the fragmental synthesis of the Lys 26 side chain is performed by condensing with DIC+A or B+A+C until the resin is detected to be transparent with ninhydrin, wherein A is chosen from HOBt or HOAt, B is chosen from HBTU, HATU, TBTU, PyAOP, or PyBOP, C is chosen from DIPEA or TMP
For patients struggling with their diet and blood sugar control, this drug can significantly influence their desire to eat and improve their life
This is important because animal studies do not always translate directly to human outcomes